About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Receives Further Arbitration Process Update

October 23, 2018

Click here to read more

Post navigation

Phosphagenics Licencing Agreement Update

Receipt of R&D Tax Incentive

Related Posts

CBD soft-gel product design complete

May 21, 2021May 21, 2021

Phosphagenics Market Update

September 1, 2017

Apppointment of Consultant to Assist in Commercialising TPM for the Mass Market

June 9, 2015

Recent Posts

Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025
MEDIA | Stockhead
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.